Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The transcript discusses various products, features, subscriptions, etc. We need to see if there is any statement about the unit size of deals, orders, contracts, projects, customers, sites, or programs escalating. Key points: They talk about new subscription tiers, Premium Plus and a lower tier. They mention that Premium Plus is being tested and has promising results. They also mention that they are expanding testing and launching in coming quarters. But do they say that the size of these engagements is larger than before? Not really. They talk about new features, but not about the scale of individual deals. They also mention Badoo's brand refresh, but again not about deal size. They mention Bumble for Friends, but not about escalating unit size. They talk about international expansion, but that's about more markets, not larger individual engagements. They mention that they are seeing strong trends, but not about the size of individual contracts. There is no mention of deals, orders, contracts, projects, customers, sites, or programs being individually larger. The growth seems to be from volume (more users) and pricing (ARPPU). They mention ARPPU is down slightly due to geographic mix, but that's not about unit size escalation. They also mention that they are adding paying users, but that's volume. So the answer is NO. We need to be careful: The question asks about "successive engagements of the same kind" coming in at progressively larger size. There is no such description. They talk about new products, but not about the size of each engagement. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.